236 related articles for article (PubMed ID: 29471336)
1. Diagnostics for onchocerciasis in the era of elimination.
Unnasch TR; Golden A; Cama V; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i20-i26. PubMed ID: 29471336
[TBL] [Abstract][Full Text] [Related]
2. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
3. Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
Rebollo MP; Zoure H; Ogoussan K; Sodahlon Y; Ottesen EA; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i14-i19. PubMed ID: 29471341
[TBL] [Abstract][Full Text] [Related]
4. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
5. Onchocerciasis in Yemen: moving forward towards an elimination program.
Al-Kubati AS; Mackenzie CD; Boakye D; Al-Qubati Y; Al-Samie AR; Awad IE; Thylefors B; Hopkins A
Int Health; 2018 Mar; 10(suppl_1):i89-i96. PubMed ID: 29471343
[TBL] [Abstract][Full Text] [Related]
6. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: elimination of transmission in the north-east focus of the Bolivarian Republic of Venezuela.
Wkly Epidemiol Rec; 2017 Oct; 92(41):617-23. PubMed ID: 29028167
[No Abstract] [Full Text] [Related]
7. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
8. After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight.
Katabarwa MN; Lakwo T; Habomugisha P; Unnasch TR; Garms R; Hudson-Davis L; Byamukama E; Khainza A; Ngorok J; Tukahebwa E; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i79-i88. PubMed ID: 29471335
[TBL] [Abstract][Full Text] [Related]
9. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
10. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2019 Jul; 8(1):62. PubMed ID: 31303174
[TBL] [Abstract][Full Text] [Related]
11. Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Kamgno J; Nana-Djeunga HC; Pion SD; Chesnais CB; Klion AD; Mackenzie CD; Nutman TB; Boussinesq M
Int Health; 2018 Mar; 10(suppl_1):i49-i53. PubMed ID: 29471340
[TBL] [Abstract][Full Text] [Related]
12. Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico.
Wkly Epidemiol Rec; 2015 Oct; 90(43):577-81. PubMed ID: 26495516
[No Abstract] [Full Text] [Related]
13. For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
Gustavsen KM; Colatrella BD; McCoy T
Int Health; 2018 Mar; 10(suppl_1):i3-i6. PubMed ID: 29186497
[TBL] [Abstract][Full Text] [Related]
14. Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan.
Higazi TB; Zarroug IM; Mohamed HA; Elmubark WA; Deran TC; Aziz N; Katabarwa M; Hassan HK; Unnasch TR; Mackenzie CD; Richards F; Hashim K
Am J Trop Med Hyg; 2013 Jul; 89(1):51-7. PubMed ID: 23690554
[TBL] [Abstract][Full Text] [Related]
15. Recent updates on onchocerciasis: diagnosis and treatment.
Udall DN
Clin Infect Dis; 2007 Jan; 44(1):53-60. PubMed ID: 17143815
[TBL] [Abstract][Full Text] [Related]
16. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
17. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
[TBL] [Abstract][Full Text] [Related]
18. The role of the NGDO Coordination Group for the Elimination of Onchocerciasis.
Elhassan E; Zhang Y; Bush S; Molyneux D; Kollmann MKH; Sodahlon Y; Richards F
Int Health; 2018 Mar; 10(suppl_1):i97-i101. PubMed ID: 29471339
[TBL] [Abstract][Full Text] [Related]
19. The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
Abong RA; Amambo GN; Hamid AA; Enow BA; Beng AA; Nietcho FN; Nji TM; Njouendou AJ; Ritter M; Esum ME; Deribe K; Cho JF; Fombad FF; Enyong PI; Poole C; Pfarr K; Hoerauf A; Carlow C; Wanji S
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008926. PubMed ID: 33465080
[TBL] [Abstract][Full Text] [Related]
20. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
